September 25, 2019 05:58 AM EDTUpdated 10:23 AM

Regulators throw up another hurdle to Roche’s $4.3B Spark acquisition as questions percolate over hemophilia market domination

Don’t look for Roche’s $4.3 billion Spark $ONCE buyout — announced 7 months ago — to close anytime in the very near future.

The UK Competition and …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Reg­u­la­tors throw up an­oth­er hur­dle to Roche’s $4.3B Spark ac­qui­si­tion as ques­tions per­co­late over he­mo­phil­ia mar­ket dom­i­na­tion